Article
Discovery of reactive peptide inhibitors of human papillomavirus oncoprotein E6
2023-05-25
Abstract excerpt
<h4>ABSTRACT</h4> Human papillomavirus (HPV) infections account for nearly all cervical cancer cases, which is the fourth most common cancer in women worldwide. High-risk variants, including HPV16, drive tumorigenesis in part by promoting the degradation of the tumor suppressor p53. This degradation is mediated by the HPV early protein 6 (E6), which recruits the E3 ubiquitin ligase E6AP and redirects its activity...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c25e055f-d4b7-5b5b-9827-b8d9a5a2e5d3
- DOI
- 10.1101/2023.05.25.542341
